|
Erythromycin EstolateDrug - Erythromycin Estolate The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL
Active Ingredient(s) -
Erythromycin Estolate
Strength -
EQ 125MG BASE/5ML
Applicant -
ALPHARMA US PHARMS
New Drug Application (NDA) Number -
062353
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 18, 1982
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Alpharma Us Pharmaceuticals Division
Erythromycin Estolate
Ilosone Eq 250mg Base Capsule; Oral
Ilosone Eq 125mg Base/5ml For Suspension; Oral Ilosone Eq 100mg Base/ml Suspension/drops; Oral Erythromycin Estolate Eq 125mg Base/5ml Suspension; Oral Erythromycin 500mg Tablet; Oral Erythromycin Estolate Eq 125mg Base Capsule; Oral Erythromycin Estolate Eq 250mg Base Capsule; Oral Erythromycin Estolate Eq 250mg Base Capsule; Oral Erythromycin Estolate Eq 250mg Base Capsule; Oral Ilosone Eq 125mg Base Capsule; Oral NewDrugInformation |